Dales weekly recap tracks FDA leadership, cannabis M&A and operator growth signals

The Aug. 23 weekly recap from The Dales Report reviews the pending Heidi Overton FDA nomination, the unsolicited Curaleaf bid for Aurora, Georgia medical patient growth and public-company operating updates. For Oklahoma operators, the video is a combined watchlist for federal hemp and CBD policy and cannabis capital activity; the nomination and bid remain developing matters, not final outcomes.